SRP4647

Galectin-7 human

recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)

Manufacturer: Sigma Aldrich

Synonym(S): Gal-7, Galactein 7, Galectin7, HKL-14, PI7, p53-induced gene 1 protein

Select a Size

Pack Size SKU Availability Price
50 μG SRP4647-50-μG In Stock ₹ 40,711.40

SRP4647 - 50 μG

₹ 40,711.40

In Stock

Quantity

1

Base Price: ₹ 40,711.40

GST (18%): ₹ 7,328.052

Total Price: ₹ 48,039.452

biological source

human

recombinant

expressed in E. coli

Assay

≥98% (HPLC)≥98% (SDS-PAGE)

form

lyophilized

mol wt

~15.4 kDa

packaging

pkg of 50 μg

storage condition

avoid repeated freeze/thaw cycles

impurities

endotoxin, tested

NCBI accession no.

P47929

UniProt accession no.

P47929

Related Products

Img

Sigma Aldrich

SRP2152

recombinant, expressed in E. coli, ...

Img

Sigma Aldrich

SRP3032

recombinant, expressed in CHO cells...

Img

Sigma Aldrich

SAE0067

His tagged recombinant protein, lyo...

Img

Sigma Aldrich

164599

--

Img

Sigma Aldrich

SRP6274

recombinant, expressed in HEK 293 c...

Img

Sigma Aldrich

E2039

recombinant, expressed in E. coli, ...

Img

Sigma Aldrich

NGLYFL-RO

--

Img

Sigma Aldrich

P6236

recombinant, expressed in E. coli, ...

Description

  • General description: LGALS7 (galectin-7) is from the galectin family of β-galactoside-binding proteins. It is mainly present in the stratified epithelia, hair follicles and thymic Hassall′s corpuscles. The protein localizes in the nucleus and cytoplasm, and exists as a homodimer.[1][2] Recombinant Human Galectin-7 is a 15.4kDa protein consisting of 136 amino acid residues
  • Biochem/physiol Actions: LGALS7 (galectin-7) helps in maintaining skin homeostasis, particularly after skin injury. It is also involved in keratinocyte proliferation and differentiation via JNK1 (c-Jun N-terminal kinase)-miR-203-p63 pathway.[1] LGALS7 is a biomarker for skin condition and skin barrier disruption.[3] In HeLa cells, it induces apoptosis most likely via JNK signaling. LGALS7 is downregulated in SV40-transformed cells and squamous cell carcinoma cells.[1] Change in its activity/expression is associated with the progression of various epithelia-associated cancers.[4] LGALS7 also helps in postmenstrual endometrial re-epithelialization.[2]
  • Physical form: Sterile filtered and Lyophilized without additives.
  • Reconstitution: Centrifuge the vial prior to opening. Avoid freeze-thaw cycles.

Compare Similar Items

Show Difference

Img

Sigma Aldrich

SRP4647

recombinant, expressed in E. coli, ...


biological source:
human

recombinant:
expressed in E. coli

Assay:
≥98% (HPLC)≥98% (SDS-PAGE)

form:
lyophilized

mol wt:
~15.4 kDa

packaging:
pkg of 50 μg

storage condition:
avoid repeated freeze/thaw cycles

impurities:
endotoxin, tested

NCBI accession no.:
P47929

UniProt accession no.:
P47929

Img

Sigma Aldrich

SRP4702

recombinant, expressed in E. coli, ...


biological source:
human

recombinant:
expressed in E. coli

Assay:
≥95% (HPLC)≥95% (SDS-PAGE)

form:
lyophilized

mol wt:
~11.2 kDa

packaging:
pkg of 20 μg

storage condition:
__

impurities:
endotoxin, tested

NCBI accession no.:
NM_001901

UniProt accession no.:
P29279

Img

Sigma Aldrich

SRP4739

recombinant, expressed in E. coli, ...


biological source:
human

recombinant:
expressed in E. coli

Assay:
≥95% (HPLC)≥95% (SDS-PAGE)

form:
lyophilized

mol wt:
~29.7 kDa

packaging:
pkg of 25 μg

storage condition:
avoid repeated freeze/thaw cycles

impurities:
endotoxin, tested

NCBI accession no.:
AAD30179

UniProt accession no.:
P49763

Img

Sigma Aldrich

SRP4757

recombinant, expressed in E. coli, ...


biological source:
human

recombinant:
expressed in E. coli

Assay:
≥98% (HPLC)≥98% (SDS-PAGE)

form:
lyophilized

mol wt:
~13 kDa

packaging:
pkg of 20 μg

storage condition:
avoid repeated freeze/thaw cycles

impurities:
endotoxin, tested

NCBI accession no.:
Q9NR23

UniProt accession no.:
Q9NR23